2026 Robert I. Fox: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	66	2717	2503	1294	1183	197	28453

Robert I. Fox publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert I. Fox sits on this spectrum.

62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert I. Fox D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert I. Fox sits on this spectrum.

40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert I. Fox is affiliated with Scripps Health in the United States and has contributed extensively to the field of Medicine, with a focus on several related subfields including Physiology, Immunology, Rheumatology, Public Health, Environmental and Occupational Health, and Genetics.

Their work addresses a range of topics notably centered on Salivary Gland Disorders and Functions, Ocular Surface and Contact Lens, Systemic Lupus Erythematosus Research, Diabetes and associated disorders, Galectins and Cancer Biology, Olfactory and Sensory Function Studies, and the Lymphatic System and Diseases.

Key recent papers authored by Robert I. Fox include:

Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial (2021, The Lancet)
2023 International Rome consensus for the nomenclature of Sjögren disease (2025, Nature Reviews Rheumatology)
Emerging treatment for Sjögren's disease: a review of recent phase II and III trials (2023, Expert Opinion on Emerging Drugs)
Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren's Syndrome: Clues for a Personalized Medicine (2021, Frontiers in Immunology)
Rethinking Sjögren Beyond Inflammation: Considering the Role of Nerves in Driving Disease Manifestations (2024, Eye & Contact Lens Science & Clinical Practice)

Their research has been disseminated in various publication venues, including:

The Lancet
Nature Reviews Rheumatology
Expert Opinion on Emerging Drugs
Eye & Contact Lens Science & Clinical Practice
The Ocular Surface

Robert I. Fox has collaborated frequently with several co-authors, with multiple joint publications alongside Xavier Mariette, Salvatore De Vita, Simon Bowman, Thomas Dörner, and Benjamin A. Fisher.

Best Publications

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

C Vitali;S Bombardieri;R Jonsson;H M Moutsopoulos

5597
Citations
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

Michael E. Weinblatt;Joel M. Kremer;Arthur D. Bankhurst;Ken J. Bulpitt

2722
Citations
Sjögren's syndrome

Robert I Fox

2513
Citations
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate

Vibeke Strand;Stanley Cohen;Michael Schiff;Arthur Weaver

1009
Citations
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

Mansun Law;Toshiaki Maruyama;Jamie Lewis;Erick Giang

685
Citations
Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.

R. I. Fox;Ho-Il Kang;D. Ando;J. Abrams

574
Citations
Mechanism of action of hydroxychloroquine as an antirheumatic drug

Robert I. Fox

567
Citations
Sjogren’s syndrome:

Robert I Fox;Paul Michelson;Carlos A Casiano;Joichiro Hayashi

534
Citations
Primary Sjogren syndrome: clinical and immunopathologic features

Robert I. Fox;Francis V. Howell;Robert C. Bone;Paul E. Michelson

490
Citations
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody

E G Engleman;R Warnke;R I Fox;J Dilley

449
Citations
Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.

T C Adamson;R I Fox;D M Frisman;F V Howell

425
Citations
Beneficial Effect of Artificial Tears Made with Autologous Serum in Patients with Keratoconjunctivitis Sicca

Robert I. Fox;Raymond Chan;Joseph B. Michelson;Jonathan B. Belmont

417
Citations
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate

Stanley Cohen;Grant W. Cannon;Michael Schiff;Arthur Weaver

413
Citations
Mechanism of action for leflunomide in rheumatoid arthritis.

Robert I. Fox;Matthias L. Herrmann;Costakis G. Frangou;Geoffrey M. Wahl

405
Citations
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium.

S Jalkanen;AC Steere;RI Fox;EC Butcher

389
Citations
Update in Sjögren syndrome.

Robert I. Fox;Michael Stern;Paul Michelson

379
Citations
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.

Unknown

352
Citations
Pathogenesis of Sjögren's syndrome.

Robert I. Fox;Ho-Il Kang

329
Citations
Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome.

R I Fox;G Pearson;J H Vaughan

327
Citations
Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis

R I Fox;S Fong;N Sabharwal;S A Carstens

316
Citations
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies

Ronald Levy;Jeanette Dilley;Robert I. Fox;Roger Warnke

266
Citations

Frequent Co-Authors

Dennis A. Carson University of California, San Diego

John H. Vaughan Scripps Health

Thomas J. Kipps University of California, San Diego

Michael E. Stern University of Cologne

Gregg J. Silverman New York University

Dennis R. Burton Scripps Research Institute

Edward K. L. Chan University of Florida

Irving L. Weissman Stanford University

Stephen C. Pflugfelder Baylor College of Medicine

Ian M. Jones University of Reading

External Links

Personal website of Robert I. Fox

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced nursing degrees such as a Psychiatric-Mental Health Nurse Practitioner (PMHNP) can open diverse career opportunities. Exploring top online pmhnp programs helps prospective students find quality education paired with strong clinical placement rates.

Cost is often a key consideration. Fortunately, there are options available among the cheapest online pmhnp programs that balance affordability with accredited curricula, allowing students to advance their careers without overwhelming debt.

Understanding the financial rewards of these pathways is equally important. The dnp salary by state illustrates the variability in nurse practitioner earnings nationwide, providing insight into potential geographic advantages based on specializations and credentials.

Moreover, nurses seeking to specialize further can consider transitioning roles within the field. Guidance on how to move from a Family Nurse Practitioner (FNP) role to a more specialized acute care position is detailed in fnp to acnp resources, highlighting career flexibility and advancement avenues.